MedTrace Logo

Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device

NCT04871581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-05-04

No results posted yet for this study

Summary

Single blinding study comparing FDA cleared device for prevention of medically diagnosed migraine pain to placebo.

Conditions

  • Chronic Migraine, Headache

Interventions

DEVICE

NTI-tss

FDA cleared device for prophylactic treatment of medically diagnosed migraine pain

DEVICE

Placebo

Similar to Device, but having no influence on clenching intensity

Sponsors & Collaborators

  • ChairsideSplint.com

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-06-30
Completion
2020-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04871581 on ClinicalTrials.gov